This observation illustrates theusefulness of cystatin C in the elderly with CKD, in whom important decisions aboutCKD management and ESRD preparation have to be considered, as it may allow us tobetter predict CKD progression and appreciate the competitive ESRD versus death risk11. This evidence concerns the gene CST3 and chronic kidney disease.